http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017276231-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6b2aa9312d14cd3baf8ea70eff572bf |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 |
| filingDate | 2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffb0bb561306be960bf93d87402a05a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5834afb8cd671ade15e83e253501c03a |
| publicationDate | 2019-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2017276231-B2 |
| titleOfInvention | Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders |
| abstract | Abstract Disclosed herein are methods of treating conditions, which may be associated with elevated levels of plasma cells and/or B-cells, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof. See Figs 6A and 6B. WO102015/023786 PCT/US2014/050943 Liiieage- Sca I. cKitl joy .x0 3 -J CONTROL 30rng/kg 10 0 mg lko Siglec-F0 l~Ruhi 0~106 * LU - CONTROL 30ra'kg 100rng/kg |
| priorityDate | 2013-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 403.